Emergency medication
Ended Awarded Last action
- Contract number
- 36C26220N0864
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $57,423
Award facts
- Contract value 100% obligated
- $57,422.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$11,591 | |
| Original award | $69,013 |
About this award
This federal contract award was issued by the Veterans Integrated Service Network 22 (VISN 22), which is part of the U.S. Department of Veterans Affairs (VA), to Takeda Pharmaceuticals America, Inc., a subsidiary of the Japan-based Takeda Pharmaceutical Company Limited. The $57,422.55 firm-fixed-price contract is for the delivery of emergency medications, primarily specialty oncology drugs such as ICLUSIG (ponatinib) and NINLARO (ixazomib), to various VA medical facilities across the country. The contract is a Blanket Purchase Agreement (BPA) call against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs, and has an ultimate completion date of January 27, 2021. There is no set-aside designation for this contract.
Quick answers
Who was awarded contract 36C26220N0864?
36C26220N0864 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on July 28, 2020.
How much is contract 36C26220N0864 worth?
The government has obligated $57,423 on 36C26220N0864.
Is contract 36C26220N0864 an order under another contract?
Yes. 36C26220N0864 is a BPA call under 36F79718D0586-36E79720A0001, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26220N0864 competed?
The extent of competition for 36C26220N0864 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award